IB. Lumholtz, [Drug information. Therapeutic main group: anti-epileptics - anticonvulsants. Succinimides (ethosuximide and phensuximide), oxazolidines (trimethadione and paramethadione), sulfonamide groups (acetazolamide and sulthiame)]., in Sygeplejersken, vol. 77, n. 8, Feb 1977, p. 11, PMID 584547.
DJ. Hoffman, AH. Chun, Paramethadione and metabolite serum levels in humans after a single oral paramethadione dose., in J Pharm Sci, vol. 64, n. 10, Oct 1975, pp. 1702-3, PMID 1185541.
TC. BUTLER, Metabolic demethylation of 3,5-dimethyl-5-ethyl 2,4-oxazolidinedione (paramethadione, paradione)., in J Pharmacol Exp Ther, vol. 113, n. 2, Feb 1955, pp. 178-85, PMID 13234040.
J. Schulman, Epileptic seizures controlled with paramethadione/primidone., in Vet Med Small Anim Clin, vol. 76, n. 6, Jun 1981, p. 827, PMID 6911910.
TE. REICHELDERFER, PH. PEARSON; S. LIVINGSTON, Thrombocytopenic purpura occurring in association with paradione (paramethadione) and dilantin sodium (phenytoin sodium) therapy., in J Pediatr, vol. 43, n. 1, Jul 1953, pp. 43-6, PMID 13062072.
JC. WREN, RL. NUTT, Nephrotic syndrome occurring during paramethadione therapy; report of a case with clinical remission., in J Am Med Assoc, vol. 153, n. 10, Nov 1953, pp. 918-20, PMID 13096309.
W. Heymann, Nephrotic syndrome after use of trimethadione and paramethadione in petit mal., in JAMA, vol. 202, n. 9, Nov 1967, pp. 893-4, PMID 4964568.
J. German, KH. Ehlers; A. Kowal; FV. De George; MA. Engle; E. Passarge, Possible teratogenicity of trimethadione and paramethadione., in Lancet, vol. 2, n. 7666, Aug 1970, pp. 261-2, PMID 4193708.
